The new family of products has been developed for extraction sockets, grafting for implant placement, ridge augmentation, and sinus augmentation.
The MinerOss X family comprises cancellous or cortical particulate, a moldable collagen block, and a cancellous particulate pre-loaded into a delivery syringe, which will support in optimal placement.
BioHorizons president and CEO Steve Boggan said the MinerOss X represents a significant addition to innovative tissue regeneration product portfolio.
"MinerOss X is a xenograft alternative for predictable bone regeneration and complements our highly successful line of MinerOss allografts," Boggan added.
MinerOss X particulates are available in size, ranging from 250µ to 1000µ, which offers better handling characteristics for a wide variety of regeneration procedures.
With a convenient screw-top lid, MinerOss X particulate is available in 0.25g, 0.5g, 1.0g and 2.0g easily accessible vials, while MinerOss X syringe is available in 0.25cc, 0.5cc and 1.0cc sizes for added convenience during surgery.
In addition, MinerOss X collagen is available in three sizes, which will support large and small grafting cases.
